Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 31 January 2022
Sec. Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

RETRACTED: ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14

Retracted
Danfeng Guo,,&#x;Danfeng Guo1,2,3†Xiaodan Zhang,,&#x;Xiaodan Zhang1,2,3†Honglei Cui,,Honglei Cui1,2,3Dongsheng Yu,,Dongsheng Yu1,2,3Huapeng Zhang,,Huapeng Zhang1,2,3Xiaoyi Shi,,Xiaoyi Shi1,2,3Chun Pang,,Chun Pang1,2,3Jie Li,,Jie Li1,2,3Wenzhi Guo,,Wenzhi Guo1,2,3Shuijun Zhang,,*Shuijun Zhang1,2,3*
  • 1Henan Key Laboratory for Digestive Organ Transplantation, Zhengzhou, China
  • 2Henan Research Centre for Organ Transplantation, Zhengzhou, China
  • 3Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Citation: Guo D, Zhang X, Cui H, Yu D, Zhang H, Shi X, Pang C, Li J, Guo W and Zhang S (2022) ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14. Front. Oncol. 12:821484. doi: 10.3389/fonc.2022.821484

Received: 24 November 2021; Accepted: 11 January 2022;
Published: 31 January 2022; Retracted: 10 December 2024.

Edited by:

Yinghong Shi, Fudan University, China

Reviewed by:

Jun Li, Tongji University, China
Zhi Dai, Fudan University, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.